TNRC6C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.660200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.736400E-01
Normal-vs-Stage2
2.280100E-02
Normal-vs-Stage3
5.486000E-02
Normal-vs-Stage4
2.977800E-01
Stage1-vs-Stage2
2.574000E-01
Stage1-vs-Stage3
1.586380E-01
Stage1-vs-Stage4
5.238400E-01
Stage2-vs-Stage3
4.939200E-01
Stage2-vs-Stage4
5.876400E-01
Stage3-vs-Stage4
3.609200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.967800E-02
Normal-vs-AfricanAmerican
2.190000E-01
Normal-vs-Asian
1.285610E-02
Caucasian-vs-AfricanAmerican
5.912000E-01
Caucasian-vs-Asian
1.869150E-01
AfricanAmerican-vs-Asian
1.190210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.666000E-02
Normal-vs-Female
1.203030E-01
Male-vs-Female
2.215600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.469800E-01
Normal-vs-Age(41-60Yrs)
1.632590E-01
Normal-vs-Age(61-80Yrs)
2.655800E-02
Normal-vs-Age(81-100Yrs)
5.758600E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.108200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.895000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.410200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.660400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.326370E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.052400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.396500E-02
Normal-vs-Daily Drinker
4.168000E-02
Normal-vs-Weekly Drinker
1.793600E-02
Normal-vs-Occasional Drinker
4.563700E-02
Normal-vs-Social Drinker
4.384800E-01
Non Drinker-vs-Daily Drinker
8.767000E-01
Non Drinker-vs-Weekly Drinker
8.743400E-01
Non Drinker-vs-Occasional Drinker
7.601000E-01
Non Drinker-vs-Social Drinker
1.460230E-01
Daily Drinker-vs-Weekly Drinker
9.925600E-01
Daily Drinker-vs-Occasional Drinker
8.863800E-01
Daily Drinker-vs-Social Drinker
1.498410E-01
Weekly Drinker-vs-Occasional Drinker
8.922400E-01
Weekly Drinker-vs-Social Drinker
1.808220E-01
Occasional Drinker-vs-Social Drinker
2.033000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.337220E-01
Normal-vs-Grade 2
1.087560E-01
Normal-vs-Grade 3
7.798100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.089630E-01
Grade 1-vs-Grade 3
3.783600E-02
Grade 1-vs-Grade 4
1.337220E-01
Grade 2-vs-Grade 3
3.663600E-01
Grade 2-vs-Grade 4
1.087560E-01
Grade 3-vs-Grade 4
7.798100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.080300E-02
Normal-vs-NonDiabetic
5.372000E-02
Diabetic-vs-NonDiabetic
6.769600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.195400E-03
Normal-vs-NoPancreatitis
6.266100E-02
Pancreatitis-vs-NoPancreatitis
3.391600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.335500E-02
Normal-vs-N1
2.700100E-02
N0-vs-N1
6.274200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.262400E-03
Normal-vs-TP53-NonMutant
4.470000E-01
TP53-Mutant-vs-TP53-NonMutant
4.19490000003186E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
